Clinical-stage biotech Mission Therapeutics is closing its preclinical laboratory operations in Cambridge, UK, a spokesperson confirmed to Endpoints News.
The biotech will focus on its clinical programs, MTX325 and MTX652, the spokesperson said in an ...
↧
